The groundbreaking therapy of the medication represents a exciting development in the care of type 2 diabetes. Different to existing therapies, tirzepatide targets multiple pathways – GLP-1 and the GIP hormone – https://tirzepatide-peptide670301.blogolenta.com/39079792/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment